FDA Clears Intellijoint Surgical’s Intellijoint HIP Anterior Application

March 8, 2017

Ontario-based, Intellijoint Surgical was awarded FDA marketing clearance for its intellijoint hip anterior.

The device is a 3D mini-optical navigation solution that provides measurements for cup position, leg length and offset to orthopedic surgeons performing direct anterior approach total hip arthroplasty.

The device will be available in New York, Illinois, Rhode Island and Houston, Texas in early summer 2017. — Cynthia Jessup

View today's stories